Vimarsana
Biggest News Aggregation in the World

Page 24 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Synthetic Hypericin in the Treatment of Psoriasis - Vimarsana News

Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Synthetic Hypericin in the Treatment of Psoriasis

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine - Vimarsana News

Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Key Binding Characteristics of Dusquetide to Important Intracellular Protein Identified - Vimarsana News

Key Binding Characteristics of Dusquetide to Important Intracellular Protein Identified

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Focus on Antivirals, Vaccines as Monkeypox Continues - Vimarsana News

Focus on Antivirals, Vaccines as Monkeypox Continues

As monkeypox outbreaks continue around the globe, the focus has turned to medications and vaccines. Health officials have their eye on stockpiles of smallpox drugs, which can also be used for monkeypox.

Soligenix Receives US Patent Allowance for its Thermostabilized Vaccine Platform - Vimarsana News

Soligenix Receives US Patent Allowance for its Thermostabilized Vaccine Platform

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...